Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Neurology ; 77(24): 2105-14, 2011 Dec 13.
Article in English | MEDLINE | ID: mdl-22131542

ABSTRACT

OBJECTIVE: In this study, we investigated the detailed clinical findings and underlying genetic defect in 3 presumably related Bulgarian families displaying dominantly transmitted adult onset distal myopathy with upper limb predominance. METHODS: We performed neurologic, electrophysiologic, radiologic, and histopathologic analyses of 13 patients and 13 at-risk but asymptomatic individuals from 3 generations. Genome-wide parametric linkage analysis was followed by bidirectional sequencing of the filamin C (FLNC) gene. We characterized the identified nonsense mutation at cDNA and protein level. RESULTS: Based on clinical findings, no known myopathy subtype was implicated in our distal myopathy patients. Light microscopic analysis of affected muscle tissue showed no specific hallmarks; however, the electron microscopy revealed changes compatible with myofibrillar myopathy. Linkage studies delineated a 9.76 Mb region on chromosome 7q22.1-q35 containing filamin C (FLNC), a gene previously associated with myofibrillar myopathy. Mutation analysis revealed a novel c.5160delC frameshift deletion in all patients of the 3 families. The mutation results in a premature stop codon (p.Phe1720LeufsX63) that triggers nonsense-mediated mRNA decay. FLNC transcript levels were reduced in muscle and lymphoblast cells from affected subjects and partial loss of FLNC in muscle tissue was confirmed by protein analysis. CONCLUSIONS: The FLNC mutation that we identified is distinct in terms of the associated phenotype, muscle morphology, and underlying molecular mechanism, thus extending the currently recognized clinical and genetic spectrum of filaminopathies. We conclude that filamin C is a dosage-sensitive gene and that FLNC haploinsufficiency can cause a specific type of myopathy in humans.


Subject(s)
Contractile Proteins/genetics , Distal Myopathies/genetics , Haploinsufficiency/genetics , Microfilament Proteins/genetics , Adult , Bulgaria , DNA Mutational Analysis , Female , Filamins , Genetic Linkage , Genome-Wide Association Study , Genotype , Humans , Male , Middle Aged , Pedigree
2.
Clin Genet ; 69(1): 58-64, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16451137

ABSTRACT

Subtelomeric rearrangements are believed to be responsible for 5-7% of idiopathic mental retardation cases. Due to the relative complexity and high cost of the screening methods used till now, only preselected patient populations including mostly the more severely affected cases have been screened. Recently, multiplex ligation-dependent probe amplification (MLPA) has been adapted for use in subtelomeric screening, and we have incorporated this technique into routine diagnostics of our laboratory. Since the evaluation of MLPA as a screening method, we tested 275 unselected patients with idiopathic mental retardation and detected 12 possible subtelomeric aberrations: a der(11)t(11;20)(qter;qter), a 19pter duplication, a der(18)t(18;10)(qter; pter), a 15qter deletion, a 8pter deletion, a 6qter deletion, a der(X)t(X;1)(pter;qter), a der(X)t(X;3)(pter;pter), a 5qter duplication, a 3pter deletion, and two 3qter duplications. The patients can be subdivided into two groups: the first containing de novo rearrangements that are likely related to the clinical presentation of the patient and the second including aberrations also present in one of the parents that may or may not be causative of the mental retardation. In our patient cohort, five (1.8%) subtelomeric rearrangements were de novo, three (1.1%) rearrangements were familial and suggestively disease causing, and four (1.5%) were possible polymorphisms. This high frequency of subtelomeric abnormalities detected in an unselected population warrants further investigation about the feasibility of routine screening for subtelomeric aberrations in mentally retarded patients.


Subject(s)
Chromosome Aberrations , Genetic Testing/methods , Intellectual Disability/genetics , Ligase Chain Reaction/methods , Telomere , Base Sequence , Child , Child, Preschool , DNA Probes , Female , Humans , In Situ Hybridization, Fluorescence , Infant , Karyotyping , Male , Molecular Sequence Data
3.
Curr Mol Med ; 1(4): 447-55, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11899089

ABSTRACT

A mouse model for the fragile X syndrome, the most common form of inherited mental retardation, was generated a number of years ago. It shows characteristics compatible with the clinical symptoms of human patients. These include pathological changes such as macroorchidism, behavioral problems, and diminished visuo-spatial abilities. To investigate whether the fragile X syndrome is a potentially correctable disorder, several groups attempted to 'rescue' the knockout mutation by introduction of an intact copy of the FMR1 gene in the knockout mouse. Two different types of rescue mice have been created by injection of constructs based on FMR1 cDNA or on FMR1 genomic DNA. Several pathological, behavioral and cognitive function tests were performed on these two different rescue mouse lines to compare their characteristics with those of the knockout and control littermates. Each rescue line resembled the control in some aspects though neither of the 2 lines was a full 'rescue', e.g. resemble the control in all aspects investigated. Thus, rescue of some aspects of the phenotype has been achieved by introduction of FMR1 constructs in the fragile X knockout mice. The results implicate that, even if FMR1 production is cell type specific, the quantity of the FMRP expression is highly critical as overproduction may have a harmful effect.


Subject(s)
Fragile X Syndrome/genetics , Fragile X Syndrome/therapy , RNA-Binding Proteins , Animals , Behavior, Animal , Chromosomes, Artificial, Yeast , Cognition , DNA, Complementary/genetics , Disease Models, Animal , Fragile X Mental Retardation Protein , Fragile X Syndrome/pathology , Gene Expression , Genetic Therapy , Genetic Vectors , Humans , Male , Mice , Mice, Knockout , Mice, Transgenic , Nerve Tissue Proteins/genetics , Phenotype , Testis/pathology
4.
Behav Brain Res ; 117(1-2): 127-36, 2000 Dec 20.
Article in English | MEDLINE | ID: mdl-11099766

ABSTRACT

Fmr1 knockout mice are an animal model for fragile X syndrome, the most common form of heritable mental retardation in humans. Fmr1 knockout mice exhibit macro-orchidism and cognitive and behavioural deficits reminiscent of the human phenotype. In the present study additional behavioural and cognitive testing was performed. Knockouts and control littermates were subjected to a spatial learning test using a plus-shaped water maze. Animals had to learn the position of a hidden escape platform during training trials. The position of this platform was changed during subsequent reversal trials. Previously reported deficits in reversal learning were replicated, but we also observed significant differences during the acquisition trials. A plus-shaped water maze experiment with daily changing platform positions failed to provide clear evidence for a working memory impairment, putatively underlying the spatial learning deficits. Two different test settings were used to examine the reported deficit of Fmr1 knockout mice in fear conditioning. Conditioned fear responses were observed in a contextual fear test, and the ability to acquire an emotional response was tested by means of response suppression in a conditioned emotional response procedure. Neither protocol revealed significant differences between controls and knockouts.


Subject(s)
Anxiety/psychology , Conditioning, Psychological , Fear , Fragile X Syndrome/complications , Intellectual Disability/genetics , Intellectual Disability/psychology , Maze Learning , Acoustic Stimulation , Analysis of Variance , Animals , Conditioning, Operant , Disease Models, Animal , Male , Mice , Mice, Knockout , Reinforcement, Psychology , Single-Blind Method
5.
Am J Hum Genet ; 66(1): 16-25, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10631133

ABSTRACT

In the search for genetic causes of mental retardation, we have studied a five-generation family that includes 10 individuals in generations IV and V who are affected with mild-to-moderate mental retardation and mild, nonspecific dysmorphic features. The disease is inherited in a seemingly autosomal dominant fashion with reduced penetrance. The pedigree is unusual because of (1) its size and (2) the fact that individuals with the disease appear only in the last two generations, which is suggestive of anticipation. Standard clinical and laboratory screening protocols and extended cytogenetic analysis, including the use of high-resolution karyotyping and multiplex FISH (M-FISH), could not reveal the cause of the mental retardation. Therefore, a whole-genome scan was performed, by linkage analysis, with microsatellite markers. The phenotype was linked to chromosome 16p13.3, and, unexpectedly, a deletion of a part of 16pter was demonstrated in patients, similar to the deletion observed in patients with ATR-16 syndrome. Subsequent FISH analysis demonstrated that patients inherited a duplication of terminal 3q in addition to the deletion of 16p. FISH analysis of obligate carriers revealed that a balanced translocation between the terminal parts of 16p and 3q segregated in this family. This case reinforces the role of cryptic (cytogenetically invisible) subtelomeric translocations in mental retardation, which is estimated by others to be implicated in 5%-10% of cases.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Deletion , Intellectual Disability/genetics , Translocation, Genetic/genetics , Adolescent , Adult , Child , Chromosomes, Human, Pair 16/genetics , Chromosomes, Human, Pair 3/genetics , Female , Humans , In Situ Hybridization, Fluorescence , Karyotyping , Lod Score , Male , Middle Aged , Pedigree , Syndrome , Telomere
6.
Am J Hum Genet ; 65(5): 1406-12, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10521307

ABSTRACT

Choreoathetosis is a major clinical feature in only a small number of hereditary neurological disorders. We define a new X-linked syndrome with a unique clinical picture characterized by mild mental retardation, choreoathetosis, and abnormal behavior. We mapped the disease in a four-generation pedigree to chromosome Xp11 by linkage analysis and defined a candidate region containing a number of genes possibly involved in neuronal signaling, including a potassium channel gene and a neuronal G protein-coupled receptor.


Subject(s)
Intellectual Disability/genetics , Mental Disorders/genetics , Nervous System Diseases/genetics , X Chromosome/genetics , Athetosis/genetics , Child , Chromosome Mapping , Humans , Lod Score , Luxembourg , Male , Microsatellite Repeats , Pedigree , Syndrome
7.
Eur J Hum Genet ; 7(5): 526-32, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10439957

ABSTRACT

Magnetic resonance imaging (MRI) of the brain of fragile X patients, the most frequent form of inherited mental retardation, has revealed abnormalities in the size of specific brain structures, including the cerebellar vermis, the hippocampus, and the ventricular system. We intended to quantify the differences observed in the patient studies in the fragile X knockout mouse model, which is a good model for the disease, paralleling the human disorder in having cognitive deficits, macro-orchidism, and immature dendritic spines. Therefore we set up MRI of the mouse brain which allowed us to measure the size of the brain structures reported to be abnormal in human fragile X patients in the mouse model. We did not find evidence for size alterations in various brain regions of the fragile X mouse model, but the method described may find a wide application in the study of mutant mouse models with neurological involvement.


Subject(s)
Brain/diagnostic imaging , Fragile X Syndrome/diagnostic imaging , Animals , Disease Models, Animal , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Mice , Mice, Knockout , Radiography
8.
Am J Med Genet ; 85(3): 209-13, 1999 Jul 30.
Article in English | MEDLINE | ID: mdl-10398229

ABSTRACT

We report on three brothers with mental retardation and a contracted CAG repeat in the androgen receptor (AR) gene. It is known that expansion of the CAG repeat in this gene leads to spinal and bulbar muscular atrophy (SBMA or Kennedy disease); however, contracted repeats have not yet been implicated in disease. As the range of the length of CAG repeats in the AR gene, like those of other genes associated with dynamic mutations, follows a normal distribution, the theoretical possibility of disease at both ends of the distribution should be considered.


Subject(s)
Intellectual Disability/genetics , Receptors, Androgen/genetics , Trinucleotide Repeats , Adolescent , Adult , Animals , COS Cells , DNA/chemistry , DNA/genetics , Family Health , Female , Follow-Up Studies , Humans , Male , Pedigree , Sequence Analysis, DNA , X Chromosome/genetics
9.
Am J Med Genet ; 84(3): 245-9, 1999 May 28.
Article in English | MEDLINE | ID: mdl-10331601

ABSTRACT

Large expansions of the CGG repeat in the 5' untranslated region of the FMR1 gene are found in patients with the fragile X syndrome. Amplified CGG repeats in FMR1 are unstable and show intergenerational increase from mother to offspring. The exact timing of repeat amplification, however, is unknown. We have compared the extent of CGG expansion in various tissues of this deceased fragile X patient, and found only limited variation in repeat expansion. The repeat was fully methylated in all tissues examined. Therefore, no evidence for extensive mitotic expansion of the CGG repeat during fetal or postnatal life of a fragile X patient was found, in contrast to dynamic mutations caused by CAG/CTG repeat expansion. Extensive pathological examination of this patient and his affected brother revealed no evidence for specific abnormalities relevant to fragile X syndrome; cerebellar hypoplasia, which has been reported in this disorder, was not evident in either patient.


Subject(s)
Brain/pathology , Fragile X Syndrome/genetics , Fragile X Syndrome/pathology , Mutation/genetics , Nerve Tissue Proteins/genetics , RNA-Binding Proteins , Adult , Aged , DNA/analysis , Fragile X Mental Retardation Protein , Humans , Mosaicism/genetics
10.
Hum Mol Genet ; 7(6): 999-1009, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9580664

ABSTRACT

L1 is a neural cell adhesion molecule mainly involved in axon guidance and neuronal migration during brain development. Mutations in the human L1 gene give rise to a complex clinical picture, with mental retardation, neurologic abnormalities and a variable degree of hydrocephalus. Recently, a transgenic mouse model with a targeted null mutation in the L1 gene was generated. These knockout (KO) mice show hypoplasia of the corticospinal tract. Here we have performed further studies of these KO mice including magnetic resonance imaging of the brain, neuropathological analysis and behavioral testing. The ventricular system was shown to be abnormal with dilatation of the lateral ventricles and the 4th ventricle, and an altered shape of the Sylvius aqueduct. Additionally, the cerebellar vermis of the KO mice is hypoplastic. Their exploratory behavior is characterized by stereotype peripheral circling reminiscent of that of rodents with induced cerebellar lesions.


Subject(s)
Brain Diseases/genetics , Cell Adhesion Molecules, Neuronal/physiology , Cerebellum/pathology , Cerebral Ventricles/pathology , Membrane Glycoproteins/physiology , Animals , Behavior, Animal , Brain Diseases/pathology , Cell Adhesion Molecules, Neuronal/genetics , Cognition Disorders/genetics , Disease Models, Animal , Humans , Hydrocephalus/genetics , Hydrocephalus/pathology , Leukocyte L1 Antigen Complex , Magnetic Resonance Imaging , Membrane Glycoproteins/deficiency , Membrane Glycoproteins/genetics , Memory Disorders/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurites , Neurologic Examination , Polymerase Chain Reaction
11.
Hum Genet ; 102(1): 54-6, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9490298

ABSTRACT

Molecular diagnosis of fragile X syndrome is usually performed using Southern blot analysis of DNA digested with EcoRI. In the course of diagnostic studies, we observed that a specific EcoRI restriction site in the fragile X gene (FMR1) is sometimes refractory to digestion, generating additional fragments on a Southern blot suggestive of a full mutation in FMR1. This may lead to a false-positive diagnosis of fragile X syndrome. Such additional bands are avoided by the use of HindIII instead of EcoRI. Therefore, we recommend the use of HindIII for the molecular diagnosis of fragile X syndrome.


Subject(s)
Deoxyribonuclease EcoRI/metabolism , Fragile X Syndrome/diagnosis , Fragile X Syndrome/genetics , Mutation , Blotting, Southern/methods , Deoxyribonuclease HindIII/metabolism , False Positive Reactions , Humans , Restriction Mapping/methods
12.
Neuroscience ; 76(2): 367-76, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9015322

ABSTRACT

Fmr1 knockout mice constitute a putative model of fragile X syndrome, the most common form of heritable mental disability in humans. We have compared the performance of transgenic mice with an Fmr1 knockout with that of normal littermates in hidden- and visible-platform water maze learning, and showed that knockouts exhibit subnormal spatial learning abilities and marginal motor performance deficits. During 12 training trials of the hidden-platform task, escape latency and path length decreased significantly in knockouts and control littermates, and no effect of genotype was found. During four ensuing reversal trials, however, significant differences were found between knockouts and control littermates both in escape latency and path length. During the visible-platform condition, the reversal trials also revealed a difference between knockouts and normal littermates in escape latency, but not in path length. Possibly due to marginal motor incapacity, knockouts swam significantly slower than controls during these latter trials. During both probe trials of the hidden-platform task, knockouts as well as normal littermates spent more time in the target quadrant than in the other quadrants, and percent of time spent in the target quadrant was the same in both groups; swimming velocity was not significantly different between knockouts and normal littermates during these trials. Entries in the target area during the probe trials did show a significant effect of genotype on number of entries. The present results largely confirm and extend our previous findings. Impaired spatial abilities in Fmr1 knockouts might have been due to relatively low response flexibility or high memory interference in Fmr1 knockouts. It remains unclear, however, which brain region or neurochemical system might be involved in these disabilities. We conclude that Fmr1 knockout mice might be a valid model of fragile X mental retardation.


Subject(s)
Learning Disabilities/genetics , Maze Learning/physiology , Animals , Cues , Learning Disabilities/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Reversal Learning/physiology , Space Perception/physiology , Swimming
13.
Hum Mol Genet ; 5(10): 1547-57, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8894688

ABSTRACT

Hereditary multiple exostosis (EXT) is an autosomal dominant condition mainly characterized by the presence of multiple exostoses on the long bones. These exostoses are benign cartilaginous tumors (enchondromata). Three different EXT loci on chromosomes 8q (EXT1), 11p (EXT2) and 19p (EXT3) have been reported, and recently the EXT1 gene was identified by positional cloning. To isolate the EXT2 gene, we constructed a contig of yeast artificial chromosomes (YAC) and P1 clones covering the complete EXT2 candidate region on chromosome 11p11-p12. One of the transcribed sequences isolated from this region corresponds to a novel gene with homology to the EXT1 gene, and harbours inactivating mutations in different patients with hereditary multiple exostoses. This indicates that this gene is the EXT2 gene. EXT2 has an open reading frame encoding 718 amino acids with an overall homology of 30.9% with EXT1, suggesting that a family of related genes might be responsible for the development of EXT.


Subject(s)
Chromosomes, Human, Pair 11 , Chromosomes, Human, Pair 19 , Chromosomes, Human, Pair 8 , Cloning, Molecular , Exostoses, Multiple Hereditary/genetics , Amino Acid Sequence , Base Sequence , DNA, Complementary/analysis , DNA, Complementary/genetics , Humans , Molecular Sequence Data , Sequence Alignment
14.
Am J Med Genet ; 64(2): 246-51, 1996 Aug 09.
Article in English | MEDLINE | ID: mdl-8844057

ABSTRACT

To gain more insight in the physiological function of the fragile X gene (FMR1) and the mechanisms leading to fragile X syndrome, the Fmr1 gene has been inactivated in mice by gene targeting techniques. In the Morris water maze test, the Fmr1 knockout mice learn to find the hidden platform nearly as well as the control animals, but show impaired performance after the position of the platform has been modified. As malperformance in the Morris water maze test has been associated with impaired long-term potentiation (LTP), electrophysiological studies were performed in hippocampal slices of Fmr1 knockout mice to check for the presence of LTP. Judged by field extracellular excitatory postsynaptic potential recordings in the CA1 hippocampal area, Fmr1 knockout mice express LTP to a similar extent as their wild type littermates during the first 1-2 hr after high frequency stimulation. Also, short-term potentiation (STP) was similar in both types of mice. To investigate whether Fmr1 is involved in the latter stages of LTP as an immediate early gene, we compared Fmr1 mRNA quantities on northern blots after chemical induction of seizures. A transient increase in the transcription of immediate early genes is thought to be essential for the maintenance of LTP. As no increase in Fmr1 mRNA could be detected, neither in cortex nor in total brain, during the first 2 1/2 hr after pentylenetetrazol-induced seizures, it is unlikely that Fmr1 is an immediate early gene in mice. In conclusion, we found no evidence for a function of FMR1 in STP or LTP.


Subject(s)
Fragile X Syndrome/physiopathology , Hippocampus/physiopathology , Long-Term Potentiation , Nerve Tissue Proteins/genetics , Animals , Evoked Potentials , Fragile X Mental Retardation Protein , Fragile X Syndrome/genetics , Male , Mice , Mice, Knockout , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/deficiency , RNA, Messenger/biosynthesis , RNA-Binding Proteins/genetics , Reference Values , Seizures/physiopathology , Transcription, Genetic
15.
Am J Med Genet ; 64(2): 241-5, 1996 Aug 09.
Article in English | MEDLINE | ID: mdl-8844056

ABSTRACT

Transgenic fragile X knockout mice have been constructed to provide an animal model to study the physiologic function of the fragile X gene (FMR1) and to gain more insight into the clinical phenotype caused by the absence of the fragile X protein. Initial experiments suggested that the knockout mice show macroorchidism and cognitive and behavioral deficits, abnormalities comparable to those of human fragile X patients. In the present study, we have extended our experiments, and conclude that the Fmr1 knockout mouse is a reliable transgenic model to study the fragile X syndrome.


Subject(s)
Fragile X Syndrome/genetics , Fragile X Syndrome/physiopathology , Maze Learning , Nerve Tissue Proteins/genetics , RNA-Binding Proteins , Aging/physiology , Animals , Fragile X Mental Retardation Protein , Fragile X Syndrome/psychology , Humans , Male , Mice , Mice, Knockout , Mice, Transgenic , Nerve Tissue Proteins/physiology , Organ Size , Reference Values , Testis/growth & development
16.
Am J Med Genet ; 64(2): 408-12, 1996 Aug 09.
Article in English | MEDLINE | ID: mdl-8844093

ABSTRACT

Only one missense mutation, an Ile304Asn, has been reported in the fragile X gene (FMR1). This mutation is located in the second KH domain of FMR1, and has led to the discovery of the function of the FMR1 gene product as an RNA-binding protein. The patient carrying this mutation has profound mental retardation, macroorchidism, and an "acromegalic" face with prominent supraorbital ridges, enlarged jaw, heavy brow ridges, thick lips, and a broad nose. We have studied the possible involvement of FMR1 in two maternal half-brothers with a phenotype similar to that of the patient with the Ile304Asn mutation. Both brothers had an identical number of CGG repeats in the normal size-range, and shared the same maternal Xq27 haplotype. Southern blot analysis with two overlapping FMR1 cDNA clones, spanning the total FMR1 open reading frame, showed no major deletions, insertions, or gross rearrangements. Single-strand conformation pattern (SSCP) analysis of the KH domains showed no aberrant patterns. The total open reading frame of the FMR1 gene was cloned and sequenced, but no mutation was found. Northern blot analysis showed mRNA in the normal size-range, and immunocytochemistry on individual lymphocytes indicated that FMRP, the protein product of FMR1, was present. In conclusion, it is unlikely that FMR1 plays a role in the phenotype of this patient. Other genes may be responsible for the combination of mental retardation and macroorchidism.


Subject(s)
Abnormalities, Multiple/genetics , Intellectual Disability/genetics , Nerve Tissue Proteins/genetics , Point Mutation , Testis/abnormalities , X Chromosome , Adult , Chromosome Mapping , DNA Primers , Exons , Female , Fragile X Mental Retardation Protein , Genetic Linkage , Humans , Male , Pedigree , Polymorphism, Single-Stranded Conformational , RNA-Binding Proteins/genetics , Reference Values , Trinucleotide Repeats
17.
Hum Genet ; 97(1): 49-50, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8557260

ABSTRACT

A slight increase in mean corpuscular hemoglobin (MCH) has been reported in erythrocytes from human fragile X patients. As it is difficult to perform case-controlled studies in patients with fragile X syndrome, we studied MCH in erythrocytes from transgenic mice with an Fmr1 knockout. None of the knockout mice showed increased MCH levels when compared with normal littermates. We conclude that it is unlikely that the FMR1 gene product has an effect on MCH.


Subject(s)
Erythrocytes/metabolism , Fragile X Syndrome/blood , Hemoglobins/metabolism , Nerve Tissue Proteins/genetics , Animals , Fragile X Mental Retardation Protein , Fragile X Syndrome/genetics , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Tissue Proteins/deficiency , RNA-Binding Proteins/genetics , Reference Values
18.
Genomics ; 29(2): 323-8, 1995 Sep 20.
Article in English | MEDLINE | ID: mdl-8666378

ABSTRACT

Blue cone monochromacy is an X-linked condition in which the function of both the red pigment gene (RCP) and the green pigment gene (GCP) is impaired. Blue cone monochromacy can be due to a red/green gene array rearrangement existing of a single red/green hybrid gene and an inactivating C203R point mutation in GCP. We describe here a family with blue cone monochromacy due to the presence of the C203R mutation in both RCP and GCP. The flanking sequences of the C203R mutation in exon 4 of RCP were characteristic for GCP, indicating that this mutation was transferred from GCP into RCP by gene conversion.


Subject(s)
Color Vision Defects/genetics , Gene Conversion , Retinal Cone Photoreceptor Cells/physiopathology , Rod Opsins/genetics , X Chromosome , Base Sequence , Chromosome Mapping , Color Perception/genetics , DNA Primers , Female , Genetic Linkage , Humans , Male , Molecular Sequence Data , Pedigree , Point Mutation , Polymerase Chain Reaction
19.
Am J Hum Genet ; 57(2): 382-7, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7668264

ABSTRACT

Hereditary multiple exostoses (EXT) is an autosomal dominant skeletal disorder characterized by the formation of multiple exostoses on the long bones. EXT is genetically heterogeneous, with at least three loci involved: one (EXT1) in the Langer-Giedion region on 8q23-q24, a second (EXT2) in the pericentromeric region of chromosome 11, and a third (EXT3) on chromosome 19p. In this study, linkage analysis in seven extended EXT families, all linked to the EXT2 locus, refined the localization of the EXT2 gene to a 3-cM region flanked by D11S1355 and D11S1361/D11S554. This implies that the EXT2 gene is located at the short arm of chromosome 11, in band 11p11-p12. The refined localization of EXT2 excludes a number of putative candidate genes located in the pericentromeric region of chromosome 11 and facilitates the process of isolating the EXT2 gene.


Subject(s)
Chromosomes, Human, Pair 11 , Exostoses, Multiple Hereditary/genetics , Genetic Linkage , Humans , Lod Score , Pedigree
20.
Hum Genet ; 94(5): 523-6, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7959688

ABSTRACT

The fragile X syndrome is the result of amplification of a CGG trinucleotide repeat in the FMR1 gene and anticipation in this disease is caused by an intergenerational expansion of this repeat. Although regression of a CGG repeat in the premutation range is not uncommon, regression from a full premutation (> 200 repeats) or premutation range (50-200 repeats) to a repeat of normal size (< 50 repeats) has not yet been documented. We present here a family in which the number of repeats apparently regressed from approximately 110 in the mother to 44 in her daughter. Although the CGG repeat of the daughter is in the normal range, she is a carrier of the fragile X mutation based upon the segregation pattern of Xq27 markers flanking FMR1. It is unclear, however, whether this allele of 44 repeats will be stably transmitted, as the daughter has as yet no progeny. Nevertheless, the size range between normal alleles and premutation alleles overlap, a factor that complicates genetic counseling.


Subject(s)
Fragile X Syndrome/genetics , Mutation/genetics , Nerve Tissue Proteins/genetics , RNA-Binding Proteins , Repetitive Sequences, Nucleic Acid/genetics , Alleles , Female , Fragile X Mental Retardation Protein , Haplotypes , Heterozygote , Humans , Male , Pedigree
SELECTION OF CITATIONS
SEARCH DETAIL
...